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Abstract:  Catheter ablation is an evolving treatment option in patients with atrial fibrillation. Contrast enhanced 
electrocardiogram-gated multi-detector computed tomography (MDCT) has rapidly evolved over the past few years into 
an important tool in the diagnosis of coronary atherosclerosis. There is increasing recognition that MDCT is a useful tool 
to evaluate non-coronary structures, such as cardiac chambers, valves, the coronary sinus and adjacent structures including 
pulmonary veins. In particular, MDCT is playing an increasingly important role in the evaluation of the left atrium and the 
pulmonary veins in patients undergoing catheter ablation for atrial fibrillation. It provides accurate and reliable 
identification of the pulmonary veins and anatomical relationship between the left atrium and esophagus although the 
mobile esophagus may limit the value of MDCT to reduce the risk of atrio-esophagus fistula. In this article, we will 
review the evaluation of the left atrium and pulmonary veins using MDCT in patients undergoing catheter ablation of 
atrial fibrillation.  
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CLINICAL BACKGROUND AND CATHETER 
ABLATION OF ATRIAL FIBRILLATION  
  Atrial fibrillation (AF) is the most common sustained 
arrhythmia encountered in clinical practice. Its prevalence 
increases with age and in patients with hypertension or 
structural heart disease [1]. Atrial fibrosis is the likely 
structural substrate of AF [2]. In certain patients with risk 
factors, AF promotes thrombus formation most commonly 
in left atrial appendage, and requires chronic anticoa-
gulation therapy [3]. In addition, AF is associated with 
poor exercise capacity, an increased risk of heart failure 
and all-cause mortality although its causality remains 
unclear [4,5]. Controversy surrounds the treatment stra-
tegies with AF: maintenance of sinus rhythm (rhythm 
control) versus rate-control [6-9].
  A numbers of studies 
have failed to show a benefit with rhythm-control, and the 
AFFIRM trial suggested a trend toward lower mortality 
with rate-control [6-9]. However, these results may be 
explained by a high rate of AF recurrence in these trials 
and the thromboembolic events that occurred after 
discontinuing anticoagulation therapy in patients assigned 
to rhythm-control arm [6-9]. 
 Since  Haissaguerre  M,  et al. reported successful 
elimination of AF with targeted ablation of foci in or near 
the ostia of the pulmonary veins (PVs); catheter ablation of 
AF quickly became an established treatment option for 
symptomatic patients with AF refractory to antiarrhythmics 
[10,11].
 A number of approaches have been developed, but 
they fall into two broad categories: PV isolation (PVI) and 
circumferential left atrial catheter ablation (LACA)   
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[12,13]. There may be an increased rate of adverse effects with 
more extensive circumferential ablation. They have been 
reported to include left atrial flutter, pericardial effusions, and 
atrio-espphageal fistula [14,15].
 Atrio-esophageal fistula is an 
often lethal complication, and has been associated with more 
extensive LACA procedures [14,15].  
Importance of the Pre-Procedural Imaging the Left 
Atrium and Pulmonary Veins in Catheter Ablation for 
Atrial Fibrillation 
  Catheter ablation of AF commonly involves mapping and 
ablation of PV electrical activities near the venous ostia to 
electrically isolate the veins from the left atrium. For this 
approach, it is important to accurately assess the number and 
anatomy of the PV ostia so that all veins can be treated. In 
addition, the ostial dimensions are important in the selection of 
appropriately sized circular mapping catheters. The PVs 
exhibit a complex anatomy with significant inter-patient and 
intra-patient variability in size, shape, bifurcation, and 
branching pattern [16].
 These variants include a common PV 
ostium (cojoined PV) and supernumerary (accessory) PV (Fig. 
1). The variability in PV anatomy makes AF ablation more 
challenging. Pre-procedural characterization of PV anatomy in 
a patient undergoing catheter ablation of AF facilitates 
selection of the ablation strategy and helps in guiding the 
ablation procedure in order to achieve an optimal result and 
minimize the risk of complications.  
Comparison of Imaging Modalities to Visualize the Left 
Atrium and Pulmonary Veins  
  A variety of cardiac imaging modalities including 
conventional fluoroscopy/angiography, transesophageal 
echocardiography (TEE), intra-cardiac echocardiogram (ICE), 
multi-detector computed tomography (MDCT) and magnetic 
resonance imaging (MRI), have been used for catheter 18    Current Cardiology Reviews, 2009, Vol. 5, No. 1  Ito and Dajani 
navigation during ablation procedures [16-18].
 Pulmonary 
angiography with multiple wedge injections into the 
pulmonary arteries, and selective PV angiography after 
trans-septal puncture were considered to be the standard 
diagnostic techniques for identification of PV abnormal-
ities but are invasive and may provide inaccurate 
measurement due to projection errors [17].
  TEE is 
suboptimal for proper atrio-venous junction evaluation and is 
inadequate for visualization of more proximal portions of the 
PVs [17].
 MDCT and MRI of the left atrium and PVs may be 
the most appropriate techniques with which to define the 
morphology and size of PVs before ablation procedures 
[19,20].
  MRI is contraindicated in patients who have 
pacemakers or defibrillators, and its usage is limited by time-
consuming acquisition processes. Although, to our knowledge, 
no studies have been published that compare the relative 
merits of CT versus MRI in this context, MDCT is becoming a 
more popular non-fluoroscopic navigation tool during catheter 
ablation for AF.  
 Wood  MA,  et al. reported that MDCT identifies the 
greatest number of PV ostia among 4 modalities including 
MDCT, ICE, TEE, and venography, and its estimations of PV 
ostial dimensions are all significantly correlated with the 
dimensions estimated by ICE (r=0.57) and venography 
(r=0.52) [17].
  PV ostial diameters were underestimated by 
TEE and overestimated by venography, compared with MDCT 
or ICE [17]. Furthermore, the study showed MDCT could 
detect more additional PV branches than ICE, and ICE 
underestimated PV ostial diameters [18]. 
  Left atrial volume (LAV) has been reported to be a 
superior measure as a predictor of the cardiovascular outcomes 
in broad patient populations [21,22]. Transthoracic 
echocardiography remains the most widely used method for 
evaluation of left atrial size and function. Indeed, 2-
dimensional (2-D) and 3-dimensional (3-D) echocardiography 
provide an accurate and reproducible estimate of LAV, and 
they allow us to evaluate PV inflow and trans-mitral inflow 
patterns [23,24].
  Besides, TEE is considered the standard of 
reference for exclusion of atrial or atrial appendage thrombi 
[25].
 However, echocardiography has some critical limitations. 
First, the quality of echocardiographic images can be limited 
by patient’s body such as obesity and obstructive lung disease. 
Second, the left atrium is not a symmetrically shaped 3-D 
structure, and left atrial enlargement may not occur in a 
uniform fashion. Therefore, one-dimensional assessment is 
unlikely to be a sensitive assessment of left atrial size change. 
Even 2-D echocardiographic assessment of left atrial volume 
may be inaccurate; it was reported to underestimate LAV 
systematically when compared with MDCT or MRI 
quantitation [19,20]. 
 
 
Fig. (1). Variations in pulmonary vein patterns. A: Normal 
pulmonary veins; B: Conjoined left pulmonary veins; C: Accessory 
pulmonary vein. 
Table 1.  Comparison of Left Atrial Volume Variables Between 64 Slice CT with Retrospective ECG Gate and Prospective ECG 
Gate 
 
  Retrospective ECG gate  Prospective gate at 60% RR interval  Prospective gate at 70 % RR interval  p Value 
Phase of RR interval with 
max LAV (%) †  32.3±6.3  60  70  <0.001 
Max LAV (ml)  93.9±32.9  76.4±28.1  75.0±30.4  <0.001 
Mini LAV (ml)  51.5±30.2  NA  NA  NA 
LA output (ml)  42.4±16.8  NA  NA  NA 
LAEF (%)  46.8±16.5  NA  NA  NA 
 
†: For calculation, phase of RR interval was considered continuous valuables.  
ECG: electrocardiogram, LAV: left atrium volume, LAEF: left atrial ejection fraction, NA: not available Evaluation of the Pulmonary Veins and Left Atrial Volume  Current Cardiology Reviews, 2009, Vol. 5, No. 1    19 
 
 
Fig. (2). Measurements of size of pulmonary vein ostium. 
 
Fig. (3). Paintbrush technique to calculate left atrial volume at each slice, excluding pulmonary veins and left atrial appendage. 20    Current Cardiology Reviews, 2009, Vol. 5, No. 1  Ito and Dajani 
Applications of MDCT in the Evaluation of Left 
Atrium and Pulmonary Veins in Patients Undergoing 
Catheter Ablation of Atrial Fibrillation 
  Prospective electrocardiogram (ECG)-gating has been 
commonly used as a method to evaluate the left atrium and 
PVs [26].
 Construction of 3-D left atrium and PVs model is 
processed using volume analysis software. Identification of 
the number and size of the PVs, draining pattern into the 
left atrium are assessed from the axial source slices. PV 
ostial diameters defined as the longest distance between 
two ostial points in the same plane in two orthogonal views 
are traced manually (Fig. 2). The 3-D images of left atrium 
can be acquired using different acquisition techniques with 
MDCT. Prospective ECG-gating acquisition and construc-
tion of the images in diastole seem commonly used for 
LAV measurement [26].
  However, the specific gating 
protocol was not disclosed in most of the previous reports, 
while there were only a few reports using the retrospective 
protocol [26-28].
 To the best of our knowledge, no study 
comparing the merits of prospective versus retrospective 
gating in the evaluation of left atrial volume and function 
has been published to date.  
  We conducted the study analyzing the LAV of 30 
patients referred for cardiac MDCT using retrospective 
gating to see if one phase can accurately be used routinely 
for maximal LAV. LAV was measured by manually 
tracing the left atrium in each slice of the CT scan from the 
level of the mitral annulus to the roof of the left atrium. 
The left atrial appendage and PVs are excluded at their 
ostia (Fig. 3). Of a total 30 patients, 17 patients (56.7%) 
had maximal LAV at 30% phase of the R-R interval, and 
23 patients (76.7%) had minimal LAV at 90 % phase (Fig. 
4). Compared with retrospective gating method, 
prospective gating at 60% or 70% of the R-R interval 
significantly underestimated maximal LAV with a mean 
difference of 17.5±7.9mL and 17.5±8.8mL, respectively. 
Minimal LAV and LAEF could only be calculated using 
retrospective method (Table 1). 
 
Fig. (4). Left atrial volume (mean value ± standard deviation) in 
each phase of the R-R interval using retrospective ECG-gating 
method, *: p <0.001. 
  Acquired PV stenosis after AF ablation is rare but serious 
complication of misplaced radiofrequency energy within the 
PVs [15]. The evaluation for PV stenosis is done by inspection 
of the PV in multiple projections for change in luminal 
diameter.
 
  Electro-anatomical map (EAM) technology is the 
traditional method used to provide anatomic guidance for 
techniques used to isolate the PVs [29].
 Creating an EAM is 
time consuming and may be technically difficult. MDCT 
images can be integrated with EAM data to allow the 
electrophysiologist to track ablation sites on a 3-D anatomical 
model of the left atrium and PVs. (Fig. 5) [30,31].
 The MDCT 
images integrated into an EAM or fluoroscopy were shown to 
reduce the fluoroscopic time and improve the success of 
catheter ablation of AF [30-32]. 
 
Fig. (5). Left atrium and pulmonary veins: Integrated images of 
electro-anatomical mapping with three-dimensional computed 
tomographic images. 
  In addition, it was reported that the MDCT images could 
depict the anatomical relationship between the left atrium and 
esophagus [33,34].
 On the other hand, Good, et al. showed that 
the esophagus was often mobile and shifted sideways by 2cm 
in a majority of patients undergoing catheter ablation under 
conscious sedation. Therefore, real-time imaging of the 
esophagus such as fluoroscopy may be necessary to reduce the 
risk of the thermal injury to the esophagus during the 
procedure [35]. 
  There are several drawbacks for the routine use of MDCT 
for evaluation of the left atrium and PVs. Radiation dose is a 
concern especially in young women [36].
 The typical radiation 
dose for a cardiac structure evaluation is on the order of 
10mSv. This exposure can be reduced by ECG attenuation 
techniques that limit exposure during less informative parts of 
the cardiac cycle. Since iodinated contrast is used patients with 
decreased creatinine clearance should be hydrated to avoid 
contrast nephropathy. Gating remains a limiting factor in 
patients with fast and irregular heart rates. Finally obesity 
remains an issue despite attempts to optimize acquisition 
protocol.  
CONCLUSION 
  Catheter ablation is an evolving treatment option in 
patients with AF. MDCT is playing an increasingly important Evaluation of the Pulmonary Veins and Left Atrial Volume  Current Cardiology Reviews, 2009, Vol. 5, No. 1    21 
role in the evaluation of the left atrium and PVs in such 
patients. It provides accurate and reliable identification of 
the PVs and anatomical relationship between the left 
atrium and esophagus although the mobile esophagus may 
limit the value of MDCT to reduce the risk of atrio-
esophagus fistula. Retrospective ECG-gating is necessary 
for accurate assessment of LAV and LAEF. 
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